NANOPRIMER - Trademark Details
Status: 700 - Registered
Serial Number
79291480
Registration Number
6422329
Word Mark
NANOPRIMER
Status
700 - Registered
Status Date
2021-07-20
Filing Date
2020-06-24
Registration Number
6422329
Registration Date
2021-07-20
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2021-05-04
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
SAITO, KIM TSUKIYO
Statements
Indication of Colors claimed
The color(s) white and blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the following: the stylized wording "NANOPRIMER" in white against a blue background.
Goods and Services
Products for medical use especially for metabolic pathways to prevent and treat acid-base imbalance, metabolic brain diseases, disorders of calcium metabolism, DNA repair-deficiency disorders, glucose metabolism disorders, hyperlactatemia, iron metabolism disorders, lipid metabolism disorders, malabsorption syndromes, metabolic syndrome X, inborn error of metabolism, mitochondrial diseases, phosphorus metabolism disorders, porphyrias, proteostasis deficiencies, metabolic skin diseases, wasting syndrome and water-electrolyte imbalance; products for medical use especially for the diagnosis and treatment of tumors; preparations for medical use especially for modifying the bioavailability of therapeutic agents; preparations for medical use especially for modifying liver functions to prevent and treat alcohol-related liver disease, non-alcoholic fatty liver disease, hepatitis, haemochromatosis, primary biliary cirrhosis and liver cancer; preparations for medical use for modifying the functions of the reticuloendothelial system to decrease reticuloendothelial system ability to trap and metabolize therapeutic agents such as nanomedicines, monoclonal antibodies, antibody-drug conjugates, small molecules, and to prevent and treat Gaucher's disease, mastocytosis, and histiocytosis; preparations based on nanomaterials for the delivery of therapeutic agents combined with nucleic acid, small molecules, proteins and peptides; nanoparticles for medical use to prevent and treat central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, organ transplant rejection; chemical reagents for medical use; bacteriological preparations for medical use; biological preparations for medical use to prevent and treat central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, organ transplant rejection; enzymes for medical use; enzyme preparations for medical use; diagnostic products for medical use to prevent and treat central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection; drugs for medical use to prevent and treat central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection; medicines for human to prevent and treat central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection; tonics for medical use to prevent and treat central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection; antibiotics; antiseptics; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection; pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection; dietetic substances preparations adapted for medical use; remedies for human medicine for the treatment of central nervous system diseases, cancer, metabolic diseases, infection, immunologic diseases, hematologic disease, rare diseases, and organ transplant rejection
Goods and Services
Scientific and technological services as well as, namely, research and design services particularly in the field of nanomedicine which is nanotechnology applied to medicine; biological research; research in bacteriology; conducting early evaluations in the field of new pharmaceuticals; design and development of new products for third parties; conducting clinical trials for others in the field of new pharmaceuticals; research services in the field of new pharmaceuticals; chemical analysis; chemical research; chemical engineering; chemical research and analysis services in the field of physico-chemical characterization and concept design; engineering work, namely, surveying; research and development of new products for third parties; technical research in the field of new pharmaceuticals; radiobiology research; research in nanoscience and nanotechnology, especially applied to medicine
Goods and Services
Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-08-14
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-14
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-14
Primary Code
044
Current Trademark Owners
Trademark Owner History
Correspondences
Name
Michele S. Katz
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1545200
International Registration Date
2020-06-24
International Publication Date
2020-08-13
International Renewal Date
2030-06-24
Auto Protection Date
2022-02-13
International Status
001 - Request for extension of protection established
International Status Date
2020-08-13
Priority Claimed In
True
Priority Claimed Date
2020-01-09
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-08-13 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-08-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-08-18 | APPLICATION FILING RECEIPT MAILED |
2020-09-27 | ASSIGNED TO EXAMINER |
2020-10-17 | NON-FINAL ACTION WRITTEN |
2020-10-18 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-11-05 | REFUSAL PROCESSED BY MPU |
2020-11-06 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2020-11-29 | REFUSAL PROCESSED BY IB |
2021-01-18 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-01-18 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-01-19 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-03-26 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-03-26 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2021-03-26 | EXAMINERS AMENDMENT -WRITTEN |
2021-03-26 | EXAMINERS AMENDMENT E-MAILED |
2021-03-26 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-03-26 | EXAMINER'S AMENDMENT ENTERED |
2021-03-26 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-04-14 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-04-14 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2021-04-14 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2021-05-02 | NOTIFICATION PROCESSED BY IB |
2021-05-04 | PUBLISHED FOR OPPOSITION |
2021-05-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-07-20 | REGISTERED-PRINCIPAL REGISTER |
2021-10-20 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2021-11-17 | FINAL DISPOSITION PROCESSED |
2021-11-17 | FINAL DISPOSITION NOTICE SENT TO IB |
2021-12-04 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
2021-12-13 | FINAL DECISION TRANSACTION PROCESSED BY IB |